Azulfidine Tablet, Delayed Release
Product Images NDC 0013-0102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azulfidine (NDC 0013-0102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Azulfidine En 01)

Chemical Structure (Azulfidine En 01)
Chemical structure of Sulfasalazine showing its molecular composition with aromatic rings, an azo group, and functional groups including amide and carboxylic acid.*
FDA Label Image

Logo (Azulfidine En 02)

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Label for Azulfidine EN-tabs, containing 500 mg of sulfasalazine as delayed release tablets, USP. The label indicates the product is manufactured by Pfizer Laboratories Div Pfizer Inc and distributed by Parhal & Upjohn Co. It includes storage instructions (25°C with excursions up to 30°C), dosage and use notes, and packaging quantity of 100 enteric-coated tablets. The label displays prescription-only status and barcodes for identification.*
FDA Label Image

Azulfidine En 04

Azulfidine En 04
Label for Azulfidine EN-tabs 500 mg delayed release tablets by Pfizer Laboratories. The label states the product name, active ingredient sulfasalazine, and strength 500 mg. It indicates a package size of 100 enteric-coated tablets and prescription use only. Storage instructions and bulk container warnings are included. Distributed by Pharmacia & Upjohn Co.*
FDA Label Image

Azulfidine En 05

Azulfidine En 05
The image shows the packaging label for Azulfidine EN-tabs 500 mg tablets, containing sulfasalazine delayed release tablets, USP. The label states the product is manufactured by Pfizer Laboratories Div Pfizer Inc and includes a 100 enteric-coated tablet count. It notes storage instructions, barcode, and distribution details by Pharmacia & Upjohn Co, a division of Pfizer Inc, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.